KRIYA THERAPEUTICS

kriya-therapeutics-logo

Kriya Therapeutics is a fully integrated platform company pioneering novel technologies and therapeutics in gene therapy. They have built a fully integrated engine that consolidates the critical infrastructure and technology needed to engineer, manufacture, characterize, and develop new gene therapies

#SimilarOrganizations #People #Financial #Event #Website #More

KRIYA THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Life Science

Founded:
2019-01-01

Address:
Redwood City, California, United States

Country:
United States

Website Url:
http://www.kriyatherapeutics.com

Total Employee:
101+

Status:
Active

Contact:
+1 833 574 9289

Email Addresses:
[email protected]

Total Funding:
450.5 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins Contact Form 7 Cloudflare Cloudflare Network Error Logging


Similar Organizations

code-biotherapeutics-logo

Code Biotherapeutics

Code Biotherapeutics is a next-generation gene therapy company pioneering the development of targeted non-viral gene therapies.

enliven-therapeutics-logo

Enliven Therapeutics

Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.

eureka-therapeutics-logo

Eureka Therapeutics

Eureka Therapeutics is a biotechnology company focusing on immunotherapies for the treatment of cancer.

fulcrum-therapeutics-logo

Fulcrum Therapeutics

Fulcrum Therapeutics is a biotechnology company that develops new medicines to treat patients with rare genetic diseases.

lycia-therapeutics-logo

Lycia Therapeutics

Lycia Therapeutics is a biotechnology company that focuses on developing technology that utilizes lysosome-targeting chimeras.

obsidian-therapeutics-logo

Obsidian Therapeutics

Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.

seismic-therapeutic-logo

Seismic Therapeutic

Seismic Therapeutic is a biotechnology company advancing machine learning for immunology drug development.

syros-pharmaceuticals-logo

Syros Pharmaceuticals

Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.

voyager-therapeutics-logo

Voyager Therapeutics

Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.


Current Advisors List

keith-manchester_image

Keith Manchester Board Member @ Kriya Therapeutics
Board_member
2022-05-01

fraser-wright_image

Fraser Wright Chief Scientific Advisor @ Kriya Therapeutics
Advisor

james-momtazee_image

James Momtazee Board of Directors @ Kriya Therapeutics
Board_member
2021-07-14

jeff-bird_image

Jeff Bird Investor @ Kriya Therapeutics
Board_member
2020-05-01

Current Employees Featured

not_available_image

Ma&s;an Muhsin
Ma'an Muhsin President and Chief Medical Officer @ Kriya Therapeutics
President and Chief Medical Officer
2022-01-01

fraser-wright_image

Fraser Wright
Fraser Wright Co-Founder @ Kriya Therapeutics
Co-Founder

theresa-heah_image

Theresa Heah
Theresa Heah Chief Medical Officer & President- Kriya Ophthalmology @ Kriya Therapeutics
Chief Medical Officer & President- Kriya Ophthalmology
2021-10-01

shankar-ramaswamy_image

Shankar Ramaswamy
Shankar Ramaswamy Co-Founder and Chief Executive Officer @ Kriya Therapeutics
Co-Founder and Chief Executive Officer
2019-10-01

curt-herberts_image

Curt Herberts
Curt Herberts President and COO @ Kriya Therapeutics
President and COO
2022-08-01

roger-jeffs_image

Roger Jeffs
Roger Jeffs Co-Founder & Vice Chairman @ Kriya Therapeutics
Co-Founder & Vice Chairman
2019-11-01

ilise-lombardo_image

Ilise Lombardo
Ilise Lombardo Chief Medical Officer @ Kriya Therapeutics
Chief Medical Officer
2021-06-01

Founder


fraser-wright_image

Fraser Wright

roger-jeffs_image

Roger Jeffs

shankar-ramaswamy_image

Shankar Ramaswamy

Investors List

camcapital_image

CAM Capital

CAM Capital investment in Series C - Kriya Therapeutics

alumni-ventures-group_image

Alumni Ventures

Alumni Ventures investment in Series C - Kriya Therapeutics

narya-capital_image

Narya Capital

Narya Capital investment in Series C - Kriya Therapeutics

bluebird-ventures_image

Bluebird Ventures

Bluebird Ventures investment in Series C - Kriya Therapeutics

jdrf-t1d-fund_image

JDRF T1D Fund

JDRF T1D Fund investment in Series C - Kriya Therapeutics

qvt-financial_image

QVT Financial

QVT Financial investment in Series C - Kriya Therapeutics

transhuman-capital_image

Transhuman Capital

Transhuman Capital investment in Series C - Kriya Therapeutics

lightswitch-capital_image

Lightswitch Capital

Lightswitch Capital investment in Series C - Kriya Therapeutics

dexcel-pharma_image

Dexcel Pharma

Dexcel Pharma investment in Series C - Kriya Therapeutics

foresite-capital_image

Foresite Capital

Foresite Capital investment in Series C - Kriya Therapeutics

Official Site Inspections

http://www.kriyatherapeutics.com Semrush global rank: 4.01 M Semrush visits lastest month: 3.09 K

  • Host name: 104.26.6.203
  • IP address: 104.26.6.203
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Kriya Therapeutics"

Our Team: Leaders in Gene Therapy - Kriya Therapeutics

Prior to SpringWorks, Lily was Senior Director of Program Management at Roivant Sciences where she led planning and organization of drug development projects through NDA preparation and coordination of due diligence reviews …See details»

Kriya Therapeutics - Crunchbase Company Profile

Kriya Therapeutics is a fully integrated platform company pioneering novel technologies and therapeutics in gene therapy. They have built a fully integrated engine that consolidates the critical infrastructure and technology needed to …See details»

Shankar Ramaswamy, MD - Kriya Therapeutics

Shankar Ramaswamy is the Co-Founder, Chairman, and Chief Executive Officer of Kriya Therapeutics. Dr. Ramaswamy was part of the early foundational team at Roivant Sciences, where he was responsible for helping to identify and …See details»

Kriya Therapeutics, Inc. | LinkedIn

Kriya Therapeutics, Inc. is a biopharmaceutical company developing gene therapies for diseases affecting millions of people around the world. With operations in Palo Alto, California and Research ...See details»

Kriya Therapeutics, Inc. Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Kriya Therapeutics, Inc. of Palo Alto, CA. Get the latest business insights from Dun & Bradstreet.See details»

Shankar Ramaswamy, M.D. - Kriya Therapeutics | LinkedIn

Dr. Ramaswamy is the Co-Founder and CEO of Kriya Therapeutics, a biopharmaceutical… · Experience: Kriya Therapeutics · Education: Harvard University · Location: Raleigh-Durham-Chapel Hill ...See details»

Kriya Therapeutics CEO and Key Executive Team | Craft.co

Kriya Therapeutics's Co-Founder, Chairman, and Chief Executive Officer is Shankar Ramaswamy. Other executives include Roger Jeffs, Co-Founder and Vice Chairman; Fraser …See details»

Kriya Therapeutics - Craft

May 17, 2020 Kriya Therapeutics is a gene therapy company. It is focused on designing and developing transformative treatments. Kriya Therapeutics' initial pipeline includes multiple AAV …See details»

Kriya Therapeutics To Grow Gene Therapy …

May 26, 2020 There’s a new biotech company setting up shop in the Triangle, and it’s flush with cash and headed up by some big names in the industry. Meet Kriya Therapeutics – the brainchild of Dr. Shankar Ramaswamy, former chief …See details»

Kriya Therapeutics, Inc.: Culture | LinkedIn

Kriya Therapeutics, Inc. Biotechnology Research Palo Alto, California 15,699 followers A fully integrated platform company aiming to revolutionize how gene therapies are designed, …See details»

Kriya Announces $150 Million Addition to its Series C, Bringing …

Jul 26, 2023 PALO ALTO, Calif. and RESEARCH TRIANGLE PARK, N.C., July 26, 2023 (GLOBE NEWSWIRE) -- Kriya Therapeutics, Inc., a biopharmaceutical company developing …See details»

Kriya Appoints Scientific Co-Founder J. Fraser Wright, Ph.D., as …

Jul 8, 2024 – Dr. Wright has three decades of experience in the research and development of viral vectors and has been involved in the development of multiple approved gene therapies …See details»

Kriya Therapeutics announces $80 million Series A financing to …

May 12, 2020 PALO ALTO, Calif. and DURHAM, N.C., May 12, 2020 /PRNewswire/ -- Kriya Therapeutics announced today that it has raised $80.5 million in a Series A financing to fund …See details»

Kriya Acquires Redpin Therapeutics, Adding Neurology Pipeline to …

Nov 16, 2022 Approximately 10,000 to 15,000 new cases of TN occur each year in the U.S., according to the National Organization for Rare Disorders (NORD). While currently available …See details»

Working at Kriya Therapeutics - Glassdoor

Glassdoor gives you an inside look at what it's like to work at Kriya Therapeutics, including salaries, reviews, office photos, and more. This is the Kriya Therapeutics company profile.See details»

Kriya Announces $150 Million Addition to its Series C, Bringing …

Jul 26, 2023 – Kriya’s therapeutic pipeline addresses a broad range of diseases that collectively affect millions of patients worldwide—with a goal of delivering transformational clinical benefits …See details»

Kriya Highlights Positive Preclinical Data for KRIYA-586, a

Sep 12, 2024 – Preclinical data demonstrate pharmacodynamic activity of KRIYA-586, an investigational gene therapy which encodes for an anti-IGF1R antibody –– Kriya anticipates …See details»

Newsroom: Gene Therapy Pipeline News - Kriya Therapeutics

Kriya shares the latest news on our pipeline of life-changing gene therapies to address common diseases.See details»

Pipeline: One-Time Gene Therapies to Address Common Diseases

Therapeutic Area Program Disease Mechanism Discovery Research IND-Enabling Clinical; Ophthalmology: KRIYA-825: Geographic Atrophy: Anti-C3 and C5See details»

linkstock.net © 2022. All rights reserved